AU2016341501B2 - Method for the enrichment of cell free nucleosomes - Google Patents

Method for the enrichment of cell free nucleosomes Download PDF

Info

Publication number
AU2016341501B2
AU2016341501B2 AU2016341501A AU2016341501A AU2016341501B2 AU 2016341501 B2 AU2016341501 B2 AU 2016341501B2 AU 2016341501 A AU2016341501 A AU 2016341501A AU 2016341501 A AU2016341501 A AU 2016341501A AU 2016341501 B2 AU2016341501 B2 AU 2016341501B2
Authority
AU
Australia
Prior art keywords
histone
nucleosomes
sample
binding agent
epitope
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2016341501A
Other languages
English (en)
Other versions
AU2016341501A1 (en
Inventor
Mark Edward Eccleston
Jacob Vincent Micallef
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Belgian Volition SPRL
Original Assignee
Belgian Volition SPRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Belgian Volition SPRL filed Critical Belgian Volition SPRL
Publication of AU2016341501A1 publication Critical patent/AU2016341501A1/en
Application granted granted Critical
Publication of AU2016341501B2 publication Critical patent/AU2016341501B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875Nucleoproteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2440/00Post-translational modifications [PTMs] in chemical analysis of biological material
    • G01N2440/12Post-translational modifications [PTMs] in chemical analysis of biological material alkylation, e.g. methylation, (iso-)prenylation, farnesylation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2016341501A 2015-10-21 2016-10-21 Method for the enrichment of cell free nucleosomes Ceased AU2016341501B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1518665.3A GB201518665D0 (en) 2015-10-21 2015-10-21 Method for enrichment of cell free nucleosomes
GB1518665.3 2015-10-21
PCT/GB2016/053305 WO2017068371A1 (en) 2015-10-21 2016-10-21 Method for the enrichment of cell free nucleosomes

Publications (2)

Publication Number Publication Date
AU2016341501A1 AU2016341501A1 (en) 2018-05-10
AU2016341501B2 true AU2016341501B2 (en) 2022-09-08

Family

ID=55131411

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2016341501A Ceased AU2016341501B2 (en) 2015-10-21 2016-10-21 Method for the enrichment of cell free nucleosomes

Country Status (12)

Country Link
US (2) US10746746B2 (enExample)
EP (2) EP3798634A1 (enExample)
JP (1) JP6831841B2 (enExample)
CN (1) CN108603884A (enExample)
AU (1) AU2016341501B2 (enExample)
CA (1) CA3002505A1 (enExample)
DK (1) DK3365684T3 (enExample)
ES (1) ES2830800T3 (enExample)
GB (1) GB201518665D0 (enExample)
PL (1) PL3365684T3 (enExample)
SG (1) SG11201803161YA (enExample)
WO (1) WO2017068371A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9605313B2 (en) 2012-03-02 2017-03-28 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
EP3597774A1 (en) 2013-03-13 2020-01-22 Sequenom, Inc. Primers for dna methylation analysis
EP3117011B1 (en) 2014-03-13 2020-05-06 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
AU2018332326B2 (en) 2017-09-18 2025-04-03 Santersus Ag Method and device for purification of blood from circulating cell free DNA
DK3759249T3 (da) 2018-03-01 2023-10-30 Epicypher Inc Kvantificering af nukleosommodifikationer ved anvendelse af kemisk definerede rekombinante nukleosomer
CN112119166B (zh) * 2018-03-13 2025-08-22 耶路撒冷希伯来大学伊萨姆研发有限公司 无细胞dna染色质免疫沉淀的诊断应用
CN109841265B (zh) * 2019-02-22 2021-09-21 清华大学 使用片段化模式确定血浆游离核酸分子组织来源的方法和系统及应用
GB201906199D0 (en) * 2019-05-02 2019-06-19 Belgian Volition Sprl Method for the detection of cancer
EP3757227A1 (en) * 2019-06-25 2020-12-30 Aarhus Universitet Cell-free chromatin immunoprecipitation (cfchip) as a measure of tumour gene expression in a sample
AU2020336928A1 (en) 2019-08-27 2022-03-24 Belgian Volition Srl Method of isolating circulating nucleosomes
GB201912251D0 (en) 2019-08-27 2019-10-09 Belgian Volition Sprl Method of isolating circulating nucleosomes
ES2988371T3 (es) * 2019-12-02 2024-11-20 Belgian Volition Srl Uso de nucleosomas libres de células como biomarcadores
TW202242145A (zh) * 2020-12-29 2022-11-01 比利時商比利時意志有限公司 核小體耗盡循環無細胞染色質片段之轉錄因子結合位點分析
US12053567B2 (en) 2021-12-27 2024-08-06 Santersus Ag Method and device for removal of circulating cell free DNA
WO2024042210A1 (en) * 2022-08-25 2024-02-29 Belgian Volition Srl Method for measuring cell free chromatin
GB202300607D0 (en) 2023-01-16 2023-03-01 Belgian Volition Srl Proteins and methods for isolating circulating nucleosomes
TW202530419A (zh) 2023-10-04 2025-08-01 比利時商比利時意志有限公司 Pcr方法
CN117904196B (zh) * 2024-01-05 2024-07-12 安徽大学 一种非小细胞肺癌组蛋白h1.4赖氨酸乙酰化点突变细胞模型的构建及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807999A (en) 1993-02-01 1998-09-15 Mt. Sinai School Of Medicine Of The City University Of New York Monoclonal antibody that distinguishes between phosphorylated and nonphosphorylated histone H1 and uses therefor
GB0319376D0 (en) * 2003-08-18 2003-09-17 Chroma Therapeutics Ltd Histone modification detection
HUE061110T2 (hu) 2009-11-05 2023-05-28 Univ Hong Kong Chinese Magzati genomelemzés anyai biológiai mintából
US9096655B2 (en) 2010-01-27 2015-08-04 Tata Memorial Centre Method for in-vivo binding of chromatin fragments
US8981066B2 (en) 2011-08-23 2015-03-17 Buck Institute For Research On Aging Epigenetic mechanisms related to DNA damage and aging
GB201115095D0 (en) * 2011-09-01 2011-10-19 Singapore Volition Pte Ltd Method for detecting nucleosomes containing nucleotides
GB201115098D0 (en) * 2011-09-01 2011-10-19 Belgian Volition Sa Method for detecting nucleosomes containing histone variants
GB201115099D0 (en) * 2011-09-01 2011-10-19 Belgian Volition Sa Method for detecting nucleosomes
WO2013084002A2 (en) * 2011-12-07 2013-06-13 Singapore Volition Pte Limited Method for detecting nucleosome adducts
US9605313B2 (en) * 2012-03-02 2017-03-28 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Sakamoto, Jun, et al. "Immunoprecipitation of nucleosomal DNA is a novel procedure to improve the sensitivity of serum screening for the p16 hypermethylation associated with colon cancer." Cancer epidemiology 34.2 (2010): 194-199. *
SCAFFIDI PAOLA ED - XIE WEN, "Histone H1 alterations in cancer", BIOCHIMICA ET BIOPHYSICA ACTA. GENE REGULATORY MECHANISMS, ELSEVIER, AMSTERDAM, NL, (2015-09-18), vol. 1859, no. 3, doi:10.1016/J.BBAGRM.2015.09.008, ISSN 1874-9399, p 533-539 *
U. DELIGEZER ET AL, "Sequence-Specific Histone Methylation Is Detectable on Circulating Nucleosomes in Plasma", CLINICAL CHEMISTRY., WASHINGTON, DC., (2008-07-01), vol. 54, no. 7, doi:10.1373/clinchem.2007.101766, ISSN 0009-9147, p1125-1131 *

Also Published As

Publication number Publication date
US20200340997A1 (en) 2020-10-29
EP3365684B1 (en) 2020-09-23
US10746746B2 (en) 2020-08-18
JP2019500582A (ja) 2019-01-10
PL3365684T3 (pl) 2021-05-04
JP6831841B2 (ja) 2021-02-17
US20190064184A1 (en) 2019-02-28
CA3002505A1 (en) 2017-04-27
SG11201803161YA (en) 2018-05-30
DK3365684T3 (da) 2020-12-21
WO2017068371A1 (en) 2017-04-27
GB201518665D0 (en) 2015-12-02
EP3365684A1 (en) 2018-08-29
AU2016341501A1 (en) 2018-05-10
EP3798634A1 (en) 2021-03-31
CN108603884A (zh) 2018-09-28
ES2830800T3 (es) 2021-06-04

Similar Documents

Publication Publication Date Title
AU2016341501B2 (en) Method for the enrichment of cell free nucleosomes
US20220334128A1 (en) Method for the enrichment of circulating tumor dna
EP3365681B1 (en) Method for detecting nucleosomes containing histone modifications and variants
CN114901832A (zh) 分离循环核小体的方法
JP2015500478A (ja) ヌクレオソームアダクト検出法
JP6777757B2 (ja) 癌検出のためのヌクレオソーム−転写因子複合体の使用
TWI726009B (zh) 用親和純化法分析生物樣品中源自腫瘤之無細胞核小體、分離生物樣品中純化之腫瘤dna、檢測生物樣品中源自腫瘤之核小體表觀遺傳表位或在動物或人類受試者中檢測癌症之方法或包括組蛋白h1結合劑之套組之用途
HK40051192A (en) Method for the enrichment of cell free nucleosomes
HK1260172A1 (en) Method for the enrichment of cell free nucleosomes
HK1260172B (en) Method for the enrichment of cell free nucleosomes
HK40050636A (en) Method for the enrichment of circulating tumor dna
HK1243764B (en) Method for the enrichment of circulating tumor dna

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired